π₯ XRP Hits The Nasdaq - XRP Crypto Analysis
1 extracted signal Β· 0 resolved Β· 1 still active
Gerhard - Bitcoin StrategyIndependent analyst profile- Source published
- 14 Oct 2026, 18:55 UTC
- Recorded by Tahlil Plus
- 14 Oct 2026, 21:23 UTC

AI-generated source summary
The video discusses the valuation of XRP via the Evernorth stock (XRPN) listing on Nasdaq. The implied price per XRP from the stock is estimated at $2.59, significantly higher than the crypto market price of $1.37. The analysis details the distribution of the $300 million raised by Evernorth, noting that a substantial portion was used to redeem shares at a higher price point than the current crypto market value. Furthermore, the video highlights the XORP.D chart, suggesting a potential trend of XRP underperforming the overall crypto market. The funding rates on Binance are negative, indicating short sellers are paying longs, which can signal bearish sentiment in the futures market. ETF flows for XRP show a positive inflow of $11 million in the week ending Oct 9, contrasting with outflows in Bitcoin, Ethereum, and Solana ETFs. However, the overall performance of XRP relative to Bitcoin has declined since August.
AI-generated summary based on the source content.
Signal outcomes at a glance
Tracking LiveSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Source processing completed
Source analysis and structured extraction completed.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- Live evaluation in progress
1 signal remains active.
Gerhard - Bitcoin Strategy
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
